Drug registration in Malaysia involves several steps: submission of a dossier to the National Pharmaceutical Regulatory Agency (NPRA), evaluation of safety, efficacy, and quality, Good Manufacturing Practice (GMP) inspection, product classification, and approval. Post-approval, the product is listed in the Quest 3+ system, and continuous monitoring ensures compliance.
